Stocks of Opko Health Inc (NASDAQ:OPK) traded higher last session on Wall Street, up 0.55% to $0.87.
OPK stock price is now -11.43% away from the 50-day moving average and -40.55% away from the 200-day moving average. The market capitalization of the company currently stands at $606.59M.
With the price target maintained at $2, Barrington Research recently Upgraded its rating from Mkt Perform to Outperform for Opko Health Inc (NASDAQ: OPK). On December 15, 2022, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $3, while ‘Barrington Research’ rates the stock as ‘Mkt Perform’
In other news, FROST PHILLIP MD ET AL, CEO & Chairman bought 500,000 shares of the company’s stock on Mar 18 ’24. The stock was bought for $437,100 at an average price of $0.87. Upon completion of the transaction, the CEO & Chairman now directly owns 210,968,225 shares in the company, valued at $183.54 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 14 ’24, CEO & Chairman FROST PHILLIP MD ET AL bought 500,000 shares of the business’s stock. A total of $444,300 was incurred on buying the stock at an average price of $0.89. This leaves the insider owning 210,468,225 shares of the company worth $183.11 million. A total of 52.91% of the company’s stock is owned by insiders.
During the past 12 months, Opko Health Inc has had a low of $0.85 and a high of $2.24. As of last week, the company has a debt-to-equity ratio of 0.24, a current ratio of 1.55, and a quick ratio of 1.22. The fifty day moving average price for OPK is $0.9830 and a two-hundred day moving average price translates $1.4641 for the stock.
The latest earnings results from Opko Health Inc (NASDAQ: OPK) was released for Dec, 2023. According to the Diagnostics & Research Company, earnings per share came in at -$0.09, inline with analysts’ expectations of -$0.09. This compares to -$0.12 EPS in the same period last year. The net profit margin was -21.87% and return on equity was -12.80% for OPK. The company reported revenue of $181.91 million for the quarter, compared to $185.34 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.85 percent. For the current quarter, analysts expect OPK to generate $183.32M in revenue.
